S&P 500 Futures
(-0.03%) 5 330.25 points
Dow Jones Futures
(-0.01%) 39 939 points
Nasdaq Futures
(-0.15%) 18 735 points
Oil
(-0.86%) $79.11
Gas
(0.22%) $2.76
Gold
(-0.81%) $2 418.80
Silver
(-2.02%) $31.77
Platinum
(-1.73%) $1 045.30
USD/EUR
(-0.10%) $0.920
USD/NOK
(-0.41%) $10.65
USD/GBP
(-0.12%) $0.786
USD/RUB
(-0.34%) $90.37

实时更新: Ocugen Inc [OCGN]

交易所: NASDAQ 部门: Healthcare 工业: Biotechnology
BUY
100.00%
return 9.47%
SELL
100.00%
return -10.94%
最后更新时间21 May 2024 @ 04:00

0.52% $ 1.920

购买 139046 min ago

@ $0.657

发出时间: 15 Feb 2024 @ 04:30


回报率: 192.46%


上一信号: Feb 14 - 22:30


上一信号: 出售


回报率: 6.16 %

Live Chart Being Loaded With Signals

Commentary (21 May 2024 @ 04:00):
Profile picture for Ocugen Inc

Ocugen, Inc., a clinical-stage biopharmaceutical company, focuses on the developing gene therapies to cure blindness diseases. The company's pipeline product includes OCU400, a novel gene therapy product candidate restoring retinal integrity and function across a range of genetically diverse inherited retinal diseases, such as retinitis pigmentosa and leber congenital amaurosis; OCU410, gene therapy candidate for the treatment of dry age-related macular degeneration (AMD); and OCU200, a novel fusion protein that is in preclinical development stage for the treatment of diabetic macular edema, diabetic retinopathy, and wet AMD...

Stats
今日成交量 3.50M
平均成交量 9.85M
市值 494.07M
EPS $0 ( 2024-05-14 )
下一个收益日期 ( $-0.0600 ) 2024-08-19
Last Dividend $0 ( N/A )
Next Dividend $0 ( N/A )
P/E -8.35
ATR14 $0.00800 (0.42%)
Insider Trading
Date Person Action Amount type
2024-04-16 Qamar Huma Buy 308 465 Option (Right to Buy)
2024-03-18 Qamar Huma Sell 0 Common Stock
2023-09-15 Breininger Michael Buy 0
2024-01-03 Musunuri Shankar Sell 180 204 Common Stock
2024-01-03 Upadhyay Arun Sell 41 633 Common Stock
INSIDER POWER
65.74
Last 96 transactions
Buy: 10 862 012 | Sell: 2 992 475

音量 相关性

長: -0.25 (neutral)
短: -0.73 (moderate negative)
Signal:(49.015) Neutral

Ocugen Inc 相关性

10 最正相关
QNST0.939
PVAL0.937
LFMDP0.935
RNA0.935
GRID0.933
DWLD0.932
AVO0.93
SG0.928
QFIN0.927
SHLD0.926
10 最负相关
UONEK-0.918
RMGC-0.904
PRTS-0.902
TTEC-0.902
ACAD-0.9
UONE-0.897
AGRX-0.895
EEIQ-0.895
NLSP-0.893
QNRX-0.892

你知道吗?

相关性是描述两个变量之间关系的统计指标。它的取值范围为-1到1,其中-1表示完全负相关(一个变量增加,另一个变量减少),1表示完全正相关(一个变量增加,另一个变量也增加),0表示没有相关性(变量之间没有关系)。

相关性可用于分析任何两个变量之间的关系,而不仅仅是股票。它通常用于金融、经济学、心理学等领域。

Ocugen Inc 相关性 - 货币/商品

The country flag -0.71
( moderate negative )
The country flag -0.77
( moderate negative )
The country flag 0.00
( neutral )
The country flag 0.00
( neutral )
The country flag -0.22
( neutral )
The country flag 0.60
( weak )

Ocugen Inc 财务报表

Annual 2023
营收: $6.04M
毛利润: $5.33M (88.34 %)
EPS: $-0.260
FY 2023
营收: $6.04M
毛利润: $5.33M (88.34 %)
EPS: $-0.260
FY 2022
营收: $0
毛利润: $-1.07M (0.00 %)
EPS: $-0.360
FY 2021
营收: $0.00
毛利润: $0.00 (0.00 %)
EPS: $-0.300

Financial Reports:

No articles found.

Ocugen Inc Options Data

Calls

Contract Name Last Trade Date (EDT) Strike Last Price Bid Ask Change % Change Volume Open Interest Implied Volatility Strike Date
No data available

Puts

Contract Name Last Trade Date (EDT) Strike Last Price Bid Ask Change % Change Volume Open Interest Implied Volatility Strike Date
No data available

Ocugen Inc

Ocugen, Inc., a clinical-stage biopharmaceutical company, focuses on the developing gene therapies to cure blindness diseases. The company's pipeline product includes OCU400, a novel gene therapy product candidate restoring retinal integrity and function across a range of genetically diverse inherited retinal diseases, such as retinitis pigmentosa and leber congenital amaurosis; OCU410, gene therapy candidate for the treatment of dry age-related macular degeneration (AMD); and OCU200, a novel fusion protein that is in preclinical development stage for the treatment of diabetic macular edema, diabetic retinopathy, and wet AMD. Ocugen, Inc. has a strategic partnership with CanSino Biologics Inc. for gene therapy co-development and manufacturing; and Bharat Biotech for the commercialization of COVAXIN in the United States market. The company is headquartered in Malvern, Pennsylvania.

关于 实时信号

此页面上呈现的实时信号有助于确定何时购买或出售NA. 信号具有高达1分钟的延迟;与所有市场信号一样,存在误差或错误的可能性。

实时交易信号不是绝对的,getagraph.com 对基于这些信号采取的任何行动概不负责,如《使用条款》中所述。这些信号是基于广泛的技术分析指标。